We observed that high expression of ASNS correlated with better prognosis in NSCLC patients, as evidenced by a slight trend of longer OS in the TCGA dataset for LUSC although it did not reach statistical significance, as well as longer DFS in the TCGA dataset for NSCLC and LUAD (Supplemental Figure 11A-F). This evidence concerns the gene ASNS and non-small cell lung carcinoma.